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Abstract.  The influenza A  virus M2 polypeptide is a 
small integral membrane protein that does not contain 
a  cleaved signal sequence, but is unusual in that it as- 
sumes the membrane orientation of a  class I  integral 
membrane protein with an NH2-terminal ectodomain 
and a  COOH-terminal cytoplasmic tail. To determine 
the domains of M2 involved in specifying membrane 
orientation, hybrid genes were constructed and ex- 
pressed in which regions of the ME protein were 
linked to portions of the paramyxovirus HN and SH 
proteins, two class II integral membrane proteins that 
adopt the opposite orientation in membranes from M2. 
A  hybrid protein (MgMH) consisting of the M2 NH2- 
terminal and membrane-spanning domains linked pre- 
cisely to the HN COOH-terminal ectodomain was 
found in cells in two forms: integrated into membranes 
in the ME topology or completely translocated across 
the endoplasmic reticulum membrane and ulti- 
mately secreted from the cell. The finding of a  soluble 
form suggested that in this hybrid protein the anchor 
function of the M2 signal/anchor domain can be over- 
ridden. A  second hybrid which contained the M2 NH2 
terminus linked to the HN signal anchor and ectodo- 
main (MgHH) was found in both the M2 and the HN 
orientation, suggesting that the M2 NH2 terminus was 
capable of reversing the topology of a  class II mem- 
brane protein.  The exchange of the M2 signal/anchor 
domain with that of SH resulted in a  hybrid protein 
which assumed only the M2 topology. Thus, all these 
data suggest that the NH2-terminal 24 residues of M2 
are important for directing the unusual membrane to- 
pology of the M2 protein. These data are discussed in 
relationship to the loop model for insertion of proteins 
into membranes and the role of charged residues as a 
factor in determining orientation. 
I 
NTF.GRAL membrane proteins that span the lipid bilayer 
once can be divided into two major groups based on 
their topology with respect to the membrane (3, 37). The 
most common are the class I proteins, which are orientated 
with an  NH2-terminal ectodomain and a  COOH-terminal 
cytoplasmic tail, e.g., the low density lipoprotein receptor 
(26), vesicular stomatitis virus (VSV) G surface glycoprotein 
(25), and the influenza virus hemagglutinin (37). Class I pro- 
teins contain an NH2-terminal  signal sequence which initi- 
ates the interaction of the growing polypeptide with the ER 
through binding with signal recognition particle (reviewed in 
reference 36), and this signal is ultimately cleaved in the lu- 
men of the ER by signal peptidase. Translocation of class I 
proteins across the ER membrane is halted by a  COOH- 
terminal stop-transfer sequence which anchors the protein in 
the membrane (27, 37). 
Class II membrane proteins are orientated with the NH2- 
terminal domain in the cytoplasm and a COOH-terminal ec- 
todomain (37). By definition, class II membrane proteins do 
not contain a cleavable NH2-terminal  signal peptide, but in- 
stead  contain a  stretch  of hydrophobic residues  near the 
NH2 terminus which acts as both an internal signal sequence 
directing integration into the membrane and as a  domain 
which anchors the polypeptide (signal/anchor domain; 27, 
37). Examples of class  II proteins  include the transferrin 
receptor (31), asialoglycoprotein receptor (35), influenza vi- 
rus neuraminidase (4), and the paramyxovirus SV5 hemagglu- 
tinin-neuraminidase (HN) and SH proteins (9,  11). 
The influenza A virus M2 polypeptide is a 97-amino acid 
integral membrane protein which is abundantly expressed at 
the surface of infected cells, where it has been suggested that 
M2 is involved in virus assembly and budding (17, 39).  The 
membrane orientation of M2 is unusual in that it cannot be 
classified as either a class I or II integral membrane protein. 
Although M2 contains a single 19-amino acid internal un- 
cleaved signal/anchor typical of class II proteins, the poly- 
peptide is orientated in the membrane in a class I topology, 
with a 24-amino acid NH2-terminal ectodomain and a 55- 
residue COOH-terminal cytoplasmic tail (17). The topology 
is uncommon, as only a few other examples of proteins con- 
taining a single membrane spanning domain with this topol- 
ogy are known, including the influenza B virus NB glycopro- 
tein (38), gp74 V-erb B of avian erythroblastosis virus (30), 
and cytochrome P450 (20,  28). 
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of M2 to the cell surface are contained within the M2 poly- 
peptide itself, as shown by analysis of the protein expressed 
from a eDNA clone (40). To investigate the regions of the M2 
protein involved in establishing its unusual topology, we have 
constructed eDNA clones which express chimeric proteins 
containing precise exchanges of the membrane spanning and 
COOH-terminal domains from M2 with those of two class 
II membrane proteins: the paramyxovirus SV5 HN and SH 
polypeptides (9, 11). Analysis of the properties of these chi- 
meric proteins indicate that some of the polypeptides can as- 
sume more than one membrane orientation, whereas others 
are completely translocated across the ER membrane and are 
ultimately secreted from the cell. The data suggest that the 
NH2-terminal  ectodomain of M2 is important in establishing 
the M2 membrane topology and that this region is capable 
of reversing the orientation of a class II integral membrane 
protein. 
Materials and Methods 
Plasmid Construction 
eDNA clones which express wild-type SV5 HN (pSVHNm) (23), SH (pSH) 
(10),  and influenza A  virus M2  proteins (pSV40-M2)  (40)  were used as 
starting materials for the construction of plasmids. Oligonucleotides were 
synthesized by the Northwestern University Biotechnology Facility on a 
DNA synthesizer  (model 380B, Applied Biosystems, Inc., Foster City, CA). 
Bacteriophage M13 containing M2 (MI3M2) or SH (MI3SH) DNA were 
constructed by inserting the entire M2 eDNA (40) or the 270 bp SH gene 
(10) into the Barn HI site of the replicative form of M13. MI3HN was con- 
structed by subeloning the 290 bp Xho I to Pst I fragment from pSVHNm 
(encoding HN 5' sequences and amino acid residues 1-81) into the corre- 
sponding sites of the replicative form of Ml3mpl9X (22)  such that single 
stranded phage DNA contained (-) sense template. 
The  M2  DNA  was altered such that  it encoded a  consensus site for 
N-linked glycosylation (Asn-Leu-Thr) at M2 residues 3-5  (17).  Site-spe- 
cific substitution (42) of nucleotides CTT (encoding leucine, residue 3) with 
AAC (asparagine) on MI3M2 was done using a 27-mer mutagenic oligonu- 
cleotide primer. The resulting eDNA (designated M13M2g)  was excised 
from the replicative intermediate by digestion with Barn HI and subcloned 
into the Barn HI site of pGEM-1 (Promega Biotec, Madison, Wl) to generate 
pGM2g.  The orientation of the insert was such that M2 mRNA-sense tran- 
scripts could be generated using the T7 promoter and T7 RNA polymerase 
(12).  To construct pSVM2g, the eDNA fragment from MI3M2g was ex- 
cised by digestion with Barn HI and inserted into the SV-40 expression vec- 
tor pSV73E/K (40). 
Chimeric proteins are named by three capital letters (M, H, or S) to de- 
scribe the three domains of the protein:  NH2-terminal, membrane span- 
ning, and COOH-terminal (see Fig.  1). A lower case "g" denotes the addi- 
tion of an  N-linked glycosylation site to  the  M2  NH2-terminal  region. 
Thus, a protein containing an M2 NH2 terminus and membrane spanning 
region linked to the COOH-terminal domain of HN is referred to as MMH. 
MgSM consists of the M2g  NH2 terminus, SH membrane spanning do- 
main, and M2 COOH-terminus. 
To construct the MgSM gene, the M2 hydrophobic domain (residues 
25-43) was substituted with that of SH (residues 17-39) in two stages using 
site-directed mutagenesis of MI3M2g. The first step used a 60-met oligo- 
nucleotide to replace the region coding for residues 25-34 of M2 with that 
coding for residues 1%28 of SH. The resulting molecule MI3MgSM' was 
then used in turn as template for mutagenesis with a 57-mer oligonucleotide 
which was used to replace the region encoding M2 residues 35-43  with 
that  coding for  SH  residues 29-39  to  produce  M13MgSM.  The  entire 
nucleotide sequence was confirmed before subcloning (designated pGMgSM) 
as described above. 
Hybrid M2/HN genes were constructed by linking specific DNA frag- 
ments through a common restriction site or by a blunt end ligation such that 
no extraneous codons were generated. New restriction enzyme sites were 
introduced into M13M2 and M13M2g at M2 nucleotides 153-158  (Xho I) 
or 96-101  (Eco RV) by oligonucleotide-directed mutagenesis using uracil- 
enriched single-stranded template as described (21). Similarly, new Xho 1 
or Sca I sites were introduced into M13HN at HN nucleotides 169-177 and 
115-120,  respectively. Resulting mutants were screened by dideoxynucleo- 
tide  sequence analysis  (29).  Mutant  fragments were  excised  from  the 
replicative form of M13 and subcioned into pGem-4 plasmids in place of 
the corresponding wild-type fragment. 
To generate MMH and MgMH a new Xho I site (CTCGAG), which en- 
codes the junction of the M2 membrane spanning and HN COOH-terminal 
domains (Leu-Glu), was used to join the HN and M2 cDNA fragments in 
a pGem-4 vector such that the resulting hybrid constructions encoded the 
M2 NH2-terminal and signal/anchor domains (residues 1-42)  linked pre- 
cisely to the HN ectodomain (residues 37-89). The resulting hybrid DNA 
fragment was  then joined with  a  segment encoding the remaining HN 
residues (90-565)  in the SV-40-based vector pSVI03 (23). 
Similarly,  MgHH  was  constructed through  the  use  of new  Eco  RV 
(GAT/ATC) and Sca I (AGT/ACT) sites added to the M2g and HN cDNA 
clones, respectively. Blunt end ligation of the Eco RV-cut M2g DNA frag- 
ment to the Sca I-cut HN segment produced a junction (GAT/ACT) encod- 
ing an Asp/Thr pair and resulted in a chimeric M2g/HN cDNA which pre- 
cisely linked the M2 NH2 terminus (residues 1-24) to the HN signal/anchor 
and ectodomains (residues  18-89).  The hybrid gene fragment was then 
joined to the segment encoding the remaining HN  residues as described 
above. Sequences were confirmed by dideoxy chain terminating analysis (29). 
Cells 
Monolayer cultures of the TC7 clone of CV-1 cells were grown in DME con- 
taining 10%  FCS. Cells were passaged and infected as described (13). 
Preparation and Expression of SV-40 
Recombinant Virus 
eDNA fragments encoding the hybrid M2/HN genes or M2g were inserted 
into the  SV-40  late  region  replacement vectors pSVI03  or pSV73E/K, 
respectively (23,  40).  Recombinant SV-40  virus stocks were prepared by 
cotransfection  of CV-1 cells with the recombinant DNA molecules and DNA 
from an SV-40 early region deletion mutant (24) using DEAE-dextran treat- 
ment as described (13). 
Isotopic Labeling of  Polypeptides in Infected Cells, 
lmmunoprecipitation, and PAGE 
Cells infected with recombinant SV-40 (13) were labeled between 40 and 
48 h postinfection with 100-200/zCi/ml Tran-3SS-label  (ICN Radiocbemi- 
cals Inc., Irvine, CA) in cysteine-methionine-free DME or (200 #Ci/ml) 
[35S]cysteine in cysteine-free DME. Immunoprecipitation of proteins from 
cell extracts solubilized in RIPA buffer was done as described (16) using 
mAb  14C2  which is specific for the M2  NH2-terminal domain (39),  or 
monospecific  polyclonal rabbit antisera to SDS-denatured HN. Immunopre- 
cipitation  of SDS-solubilized cell  extracts  was  done  as described (2). 
Briefly, cells were lysed by the addition of 1% SDS, boiled for 5 rain, and 
diluted into 4 vol of buffer (1.25%  Triton X-100,  190 mM NaCI, 60 mM 
Tris-HCI, pH 7.4, 6 mM EDTA) before incubation with sera. Samples were 
analyzed by SDS-PAGE on 10%  gels followed by fluorography (14,  15). 
M2g and MgSM were expressed from transfected pGM2g and pGMgSM 
in CV-1 cells by a  modification of previous procedures (7).  Cells were 
infected (multiplicity of infection of 20) with recombinant vaccinia virus 
vTF7-3,  which expresses the bacteriophage T7 RNA polymerase (7). Cells 
were then transfected with 20/~g of pGM2g or pGMgSM by calcium phos- 
phate precipitation. At 3 h posttransfection, cells were labeled for 1 h with 
100 #Ci/ml [35S]cysteine in cysteine-free DME, lysed in RIPA buffer,  im- 
munoprecipitated with M2-speeific mAb, and analyzed on 17.5% polyacryl- 
amide gels containing 4  M urea (16, 40). 
Endoglycosidase Analysis and Tunicamycin  Treatment 
of CeUs 
Treatment of samples with/3-endoglycosidase  H (endo H) (Miles Laborato- 
ries, Inc. Elkhart, IN) was as described previously (38). For tunicamycin 
treatment, the drug (1 /~g/ml) (Calbiochem-Behring Corp., La Jolla, CA) 
was added to cells 2 h before and maintained during the labeling period. 
Trypsinization  of Microsomal Membranes 
Monolayers of recombinant SV-40-infected CV-i cells (10-cm-diam plates) 
1. Abbreviation used in this paper:  Endo H, endoglycosidase H. 
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lar microsomal membranes were prepared  as described (1).  Each sample 
was divided into three equal parts and incubated with either buffer, trypsin 
(11 ttg/ml; Sigma Co., St. Louis, MO), or trypsin plus detergent (1% NP-40) 
at 37°C for 45 rain. After addition of trypsin inhibitor (aprotinin, 5 TI units; 
Sigma Chemical Co.),  membranes were isolated by centrifugation (35,000 
rpm, 3.5 h, 4°C) in a SW41  rotor (Beckman Instruments Inc.,  Palo Alto, 
CA) through a  10-ml sucrose cushion 00%  [wt/vol]  l0 mM Tris-HCl, pH 
8.0,  I  mM EDTA).  Pellets were boiled in 1% SDS, diluted with buffer as 
described above, immunoprecipitated with HN-specific antisera, and ana- 
lyzed by SDS-PAGE. 
Alkali Treatment of  Microsomes 
6-cm-diam plates of CV-I cells infected with recombinant SV-40 virus were 
labeled  with  (150 #Ci/ml)  Tran-3SS-label  for  1 h.  For  MgSM  and  M2g, 
vaccinia virus infected cells which had been transfected with pGMgSM or 
pGMzg were labeled at 3 h posttransfection with [3SS]cysteine  for 1 h. Af- 
ter preparation of microsomal membranes (1), 0.9 ml of lysate was clarified 
(3,000 g), mixed with 0.1 ml of I M NazCO3  (pH  11), and incubated at0°C 
for 30 min (33). The samples were centrifuged for 45 min at 40,000 rpm 
(130,000 g) at 4°C in a table top ultracentrifuge (model TLI00) using a rotor 
(model TLS-55;  both from Beckman Instruments).  Equal portions of the 
pellet and supernatant were neutralized with acetic acid, solubilized in RIPA 
buffer,  immunoprecipitated,  and analyzed by SDS-PAGE. 
Results 
Expression of Chimeric Proteins in CV-1 Cells 
To analyze the protein domains responsible for the mem- 
brane  orientation  of  M2,  recombinant  cDNA  molecules 
were constructed with precise domain exchanges such that 
they encoded the NH~-terminal ectodomain of M2, a hydro- 
phobic membrane spanning region from either M2, HN, or 
SH and the ectodomain of HN or the cytoplasmic tail of M2 
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Figure 1. Schematic diagram of the domains of the wild-type inte- 
grad membrane proteins and those of the chimeric proteins MMH, 
MgMH,  MgHH,  and MgSM.  Membrane  proteins  are  depicted 
schematically as horizontal bars consisting of  three domains: amino 
terminal (lefO, membrane spanning (middle), and carboxy terminal 
(right). Chimeric proteins are named as described in the text. N, 
amino terminus. ( v ), N-linked glycosylation sites. Proteins are not 
drawn to scale. 
Figure 2. Expression and endo- 
glycosidase treatment of M2 and 
M2g. CV-I cells  infected with 
recombinant  SV-40 expressing 
M2 or M2g were labeled for 1 h 
with [3SS]cysteine  and lysed in 
RIPA buffer. Samples were im- 
munoprecipitated with  an  M2- 
specific  monoclonal  antibody, 
and digested with (+) or with- 
out (-)/~-Endo H before analy- 
sis by SDS-PAGE. Lane C shows 
a wild-type ME lysate immuno- 
precipitated with ascites fluids 
from control SP2/O cells. 
(see Fig. 1). The analysis of the membrane orientation of the 
chimeric proteins was facilitated by the construction of an 
M2 cDNA clone which encoded an asparagine-linked gly- 
cosylation site in the M2 NH2-terminal ectodomain (M2g). 
The recombinant hybrid molecules (MMH, MgMH, MgHH, 
and MgSM) are named after the origin of the precise domains 
which were exchanged for their construction (Fig.  1). Thus, 
MMH  contains  the  NH2-terminal ectodomain and  signal- 
anchor of M2 (residues 1-42) linked precisely to the ectodo- 
main of HN (residues 37-565). The chimeric genes were in- 
serted into an SV-40 late-region replacement vector and lyric 
stocks of recombinant virus were produced. 
To examine if the newly introduced NH2-terminal glyco- 
sylation site in M2 was used, CV1 cells infected with SV-40M2 
or SV-40M2g recombinant viruses (the latter reconstructed 
and kindly made available by Hooshmand Sheshberadaran) 
were labeled for 1 h with [3sS]cysteine and immunoprecipi- 
tated with M2-specific monoclonal antibody 14C2.  As shown 
in Fig. 2, Mzg had a slower electrophoretic mobility as com- 
pared to M2  (-  lanes),  compatible with the addition of a 
single N-linked carbohydrate chain to M2g. Further evidence 
for glycosylation was provided by digesting M2g with Endo 
H,  and  finding  an  increased  electrophoretic  mobility  of 
M2g (Fig.  2,  +  lane).  The difference in mobility between 
wild-type M2 and endo H-treated M2g is due to both the 
amino  acid  change  in  M2g  and  the  N-acetylglucosamine 
residue remaining after Endo H treatment. Single amino acid 
changes in M2 have been shown previously to alter its elec- 
trophoretic mobility (17). However, when the 24-residue ec- 
todomain of M2g is fused to the 548-residue transmembrane 
and COOH-terminal domains of HN, the amino acid substi- 
tution  in  M2  does  not  detectably alter  its  electrophoretic 
mobility (see below). It will be shown elsewhere that M2g 
is abundantly expressed at the cell surface and that the carbo- 
hydrate chain remains sensitive to Endo H  digestion at all 
Parks et al.  Orientation of Chimeric Integral Membrane Proteins  2025 Figure 3. Expression of chimeric M2/HN proteins in CV-1 cells. Cells infected with recombinant SV-40 MMH, MgMH, and MgHH were 
labeled for l  h with Tran-35S-label in the absence (lanes 1, 3, 5, and 7) or presence (lanes 2, 4, 6, and 8) of tunicamycin. Cells were 
lysed in RIPA buffer and immunoprecipitated with polyclonal antisera to HN (.4) or an ME-Specific  monoclonal antibody (B, except lanes 
7 and 8), and the resulting proteins were analyzed by SDS-PAGE and fluorography. The designation of the chimeric proteins is shown 
above the lanes. Lanes 7 and 8 are marker lanes of wild-type HN expressed from recombinant virus SVHNm (23) and immunoprecipitated 
with anti-HN serum. Lanes P, SV-40 recombinant virus MMH-infected cell lysate immunoprecipitated using preimmune sera. Lane M, 
marker lane of SVS-infected  cell lysate; molecular masses (in kilodaltons) are indicated on the left. L  H, III, and/V denote forms of the 
chimeric proteins described in the text. ctHN denotes anti-HN. 
times (Sheshberadaran, H., unpublished observations). In the 
hybrid  molecules  described  below,  glycosylation  of this 
NH2-terminal region of M2 is used as a marker for translo- 
cation of this domain into the ER lumen. 
The  proteins  produced  from  the  hybrid  M2/HN  genes 
were  examined  by  infecting  CV-1 cells  with  the  various 
recombinant SV-40 viruses and labeling for 1 h with Tran- 
35S-label in the presence or absence of tunicamycin, an in- 
hibitor of asparagine-linked glycosylation. Cell lysates were 
then immunoprecipitated with antisera specific for either HN 
or the NH2-terminal domain of M2 and analyzed by SDS- 
PAGE.  In  CV1  cells infected with  recombinant virus  SV- 
HNm, which has been shown previously to express biologi- 
cally active wild-type HN (23), a single HN-specific glyco- 
sylated polypeptide species of *68,000 Mr was synthesized 
(Fig. 3, lane 7), and in the presence of tunicamycin a single 
band of '~52,000 Mr was observed (lane 8). In contrast, SV- 
40-MMH synthesized two major polypeptides, designated 
form I  (~53,000  Mr)  and  III  (-,70,000  Mr),  which  were 
reactive with antisera to HN (Fig. 3 A, lane/), but not with 
preimmune sera (lane P).  SV-40-MgMH,  which encodes 
the  MgMH  polypeptide with the additional  NH2-terminal 
glycosylation site,  synthesized in  infected cells two major 
polypeptides precipitated by HN antisera (forms I and III, 
lane 3) which have a slower electrophoretic mobility com- 
pared to MMH form I and III (lane/).  The increased size 
of the MgMH forms I and III (,x,58,000 and 75,000 Mr) was 
consistent with the addition of a carbohydrate chain to the 
NH2 terminus of these two polypeptides. In the presence of 
tunicamycin, a single MMH-specific polypeptide of ~53,000 
Mr was synthesized in both SV-40-MMH and SV-40-MgMH 
infected cells (Fig. 3 A, lanes 2 and 4), suggesting that forms 
I and III are a single polypeptide species which differ by the 
extent of carbohydrate addition. 
SV-40-MgHH synthesized two MgHH polypeptide spe- 
cies in infected cells (Fig.  3 A, lane 5), one with an elec- 
trophoretic mobility matching that of MgMH form I (~58,000 
Mr) and a second species (form II) with a mobility similar 
to wild-type HN ("~68,000  Mr).  In the presence of tunica- 
mycin, the MgHH polypeptides migrated as a single species 
of "~53,000  Mr (lane 6),  suggesting that form I and II dif- 
fered by carbohydrate addition.  Further,  the difference in 
mobility of "~ 3,000 Mr between MgMH form HI and MgHH 
form II suggests that the four HN-specific glycosylation sites 
are used equivalently. 
To examine the integrity of the M2 NH2-terminus in these 
hybrid molecules, cell lysates were immunoprecipitated with 
a  site-specific antibody (M2 monoclonal 14C2)  (39).  This 
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membranes containing M2/HN chimeric pro- 
teins.  Recombinant SV-40-infected cells  ex- 
pressing MMH, MgMH, MgHH, or HN were 
labeled for 30 min with Tran-35S-label. Micro- 
somal membranes were prepared (1) and treated 
with buffer (lane 1 ), trypsin (lane 2), or trypsin 
plus detergent (lane 3).  After centrifugation 
through a sucrose cushion, pellets were boiled 
in  1% SDS, diluted,  and immunoprecipitated 
with HN-specific antisera before analysis by 
SDS-PAGE. 
antibody recognized two forms of the hybrid polypeptides 
which matched those identified by using HN-specific sera 
(Fig. 3 B, lanes 1-6). The reactivity of these species with this 
M2  NH2-terminal-specific  mAb  indicates  that  the  NH2- 
terminal region of forms I, II, and III was present and had 
not been cleaved by signal  peptidase during translocation 
across the ER membrane. 
When a comparison of the hybrid polypeptides immuno- 
precipitated by the two antisera (Fig. 3, A and B) was made, 
another MMH-  and  MgMH-specific species  (form IV,  A) 
could be identified with the HN antisera that was not recog- 
nized by the M2 antibody. The electrophoretic mobility of 
form IV was not altered in the case of MgMH by the presence 
of the M2 NH2-terminal glycosylation site (compare Fig. 3, 
lanes 1 and 3). The precise nature of polypeptide IV has not 
been determined, but it is thought to lack the M2 NH2-ter- 
minal region and may represent a  cleavage product of the 
MMH or MgMH polypeptides by a signal peptidase-like ac- 
tivity. 
Taken together, the above data indicate that expression of 
MMH,  MgMH,  and MgHH chimeric genes in CV-1 cells 
results in the synthesis of three major protein species (forms 
I, II, and III) which differ in their glycosylation patterns. In 
addition,  a  polypeptide (form IV) was produced from the 
chimeras MMH and MgMH, and this product is thought to 
result from cleavage of its NH2-terminal region. 
Chimeric M/HN  Proteins Exist in Multiple 
Orientations in the Membrane 
Hybrid proteins I and III synthesized by MMH or MgMH 
and form I and II synthesized by MgHH differed in their ex- 
tent of glycosylation, suggesting that they may be oriented 
differently in the ER membrane. To determine biochemically 
the membrane topology of  the various hybrid species, micro- 
somal membranes isolated from recombinant SV-40-infected 
cells were treated with trypsin and the protected fragments 
analyzed. Wild-type HN was resistant to protease digestion, 
unless the membrane had been disrupted by the addition of 
detergent (Fig. 4, HN, lanes 1-3). Microsomes from recom- 
binant SV-40-infected cells expressing MMH,  MgMH, or 
MgHH were treated similarly (Fig. 4) and it was found that 
forms II and III were largely protected from digestion with 
added protease, while the majority of form I was accessible 
to proteolysis. Protein species IV is protected from digestion 
(Fig. 4, MMH, lanes I and 2), but showed a slight alteration 
Figure 5. Alkali fractionation of chimeric M:/HN proteins. CV-1 
ceils  infected with  recombinant  SV-40 expressing HN,  MMH, 
MgMH, or MgHH were radiolabeled with Tran-3SS-label for 1 h 
and microsomal membranes were prepared. Samples were adjusted 
to pH 11 by the addition of Na2CO3 and incubated at 4°C for 30 
rain. Membranes were then separated into pellet (P) and superna- 
tant (S) fractions by centrifugation as described in Materials and 
Methods.  Equal portions of the two fractions were neutralized, 
solubilized in RIPA  buffer, immunoprecipitated with anti-HN sera, 
and analyzed by SDS-PAGE. 
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trimming of the polypeptide but is an artifact due to sample 
preparation before electrophoresis; all bands in lanes 2 have 
slightly altered mobilities. 
Protection of forms II and III from proteolytic digestion 
of microsomes would indicate that the polypeptides had as- 
sumed either a membrane-anchored class II orientation or 
that they had been completely translo.cated across the mem- 
brane into the ER lumen. To distinguish between these possi- 
bilities microsomal membranes were prepared from recom- 
binant SV-40-infected cells and fractionated at alkaline pH 
by centrifugation. By this criteria, integral membrane pro- 
teins are found in the pellet fraction and membrane peripher- 
ally associated and soluble proteins are found in the superna- 
tant  (5,  12,  33).  Wild-type  HN  was  found  in  the  pellet 
fraction (Fig. 5, HN, lane P) as would be expected for an in- 
tegral membrane protein. MgHH forms I and II were found 
in the pellet fraction (Fig. 5, MgHH, lane P) suggesting that 
they are integral membrane proteins. The majority of forms 
III and IV of MMH and MgMH were extracted with alkali 
(compare lanes P and S) suggesting that they are soluble pro- 
teins. Form I of MMH and MgMH was always difficult to 
detect in these experiments. However, when it could be ob- 
served, e.g., for MgMH, it was found in the pellet fraction 
suggesting that form I is associated with membranes. As will 
be described below, form I from MMH and MgMH is an un- 
stable species in pulse-chase analysis and thus the relative 
loss of this protein during alkali fractionation is not unex- 
pected. 
The above data suggest that MMH and MgMH polypep- 
tide form III was completely translocated across the mem- 
brane  as  both  the  NH2-terminal  M2  and  COOH-terminal 
HN domains were glycosylated, the molecule is resistant to 
digestion with protease and it is found to be soluble after 
alkali fractionation. As form I of MMH, MgMH, and MgHH 
was glycosylated only at its NH2 terminus, can be digested 
with protease, and is strongly associated with membranes af- 
ter alkali fractionation, it can be deduced that form I has its 
NH2-terminal M2 region in the lumen of vesicles and that 
the molecules are orientated like natural Mz.  MgHH form 
II was not glycosylated at the M2 site (electrophoretic mo- 
bility  matching  wt  HN)  but  was  glycosylated in  the  HN 
domain, was resistant to protease digestion, and was not ex- 
tracted from membranes using the alkali fractionation proce- 
dure. These data are consistent with MgHH form II having 
assumed an HN-like class II integral membrane protein orien- 
tation. Thus, most importantly for the studies described here, 
MMH and MgMH always assumed orientations with their 
NH2 terminus translocated across the ER membrane, while 
MgHH is expressed as two forms that assume opposite orien- 
tations in membranes. 
Secretion and Stability of the Hybrid Molecules 
To provide further evidence for the nature of the chimeric 
M2/HN polypeptides, the stability of the different forms of 
the hybrids and their possible interconversion was examined. 
CV1 cells were infected with the recombinant SV-40 viruses 
and pulse-labeled with Tran-35S-label  for 30 min followed 
by incubation for varying periods (chase) with DME. At var- 
ious times after the pulse-label, cells and medium were har- 
vested,  immunoprecipitated with  anti-HN  sera,  and  ana- 
lyzed by SDS-PAGE. 
After the 30-min labeling period MMH, MgMH, or MHH 
forms I, II, III, and IV could be immunoprecipitated with 
HN-specific sera (Fig. 6, lane P) but not control sera (lane 
C). During the chase period, form I of all three hybrid mole- 
cules was degraded with a half-time of <1 h. This was not 
entirely unexpected because the HN ectodomain when held 
in the cytoplasm would be unlikely to fold into its native 
form, and thus would be a candidate substrate for proteoly- 
sis.  In the case of MgMH (B), forms I and IV were often 
difficult to separate electrophoretically (see also Fig. 3 A) but 
the result of many experiments indicated that form I and IV 
are distinct species and that it is form I  that is degraded. 
Form III was lost from cells over a prolonged chase period 
(A and B) and as only a  small amount of the molecule is 
secreted (see below), this loss of label probably reflects turn- 
over of the polypeptide. In contrast, MgHH form II was rela- 
tively stable, up to 12 h after pulse-labeling. It can be seen 
that forms II, III, and IV exhibit a progressively faster mobil- 
ity during the hours of the chase period, which probably re- 
flects carbohydrate modifications during intracelhlar transport. 
To determine if the lumen soluble polypeptide forms III 
and IV were secreted, the extracellular medium was immu- 
noprecipitated. As shown in Fig. 6, MMH and MgMH poly- 
peptides were found in the medium beginning 1 h after the 
pulse period and reaching a plateau by 9 h. The immunopre- 
cipitated polypeptides shown in Fig. 6 were from equal vol- 
ume aliquots of cell lysate or medium, and thus the unequal 
amount of proteins in the cells versus the medium, along with 
nearly complete loss from the cell by 6-9 h, suggests that 
species III and IV are turned over during the prolonged incu- 
bation. As expected for a polypeptide resistant to alkali ex- 
traction from membranes, MgHH form II was not secreted 
into the extracellular medium (Fig. 6  C). 
The degree of native folding of the hybrid molecules, their 
oligomerization and rate of transport from the endoplasmic 
reticulum to the Golgi apparatus are beyond the scope of the 
experiments reported here.  However, MgHH,  can be de- 
tected at the cell surface by indirect immunofluorescence 
using HN but not M: ectodomain-specific monoclonal anti- 
bodies (data not shown) which provides further confirmation 
of the membrane orientation of the stable MgHH form II 
protein. 
Substitution of a Class H Signal~Anchor into M2 
Does Not Alter Its Membrane Orientation 
As described above, the MgHH hybrid molecule assumes 
two approximately equal but opposite membrane orienta- 
tions.  Since this molecule contains the  M2  NH2 terminus 
linked  to  the  HN  signal/anchor  and  COOH-terminal  do- 
mains,  the relative importance of each region in bringing 
about the  inversion in  orientation of the  HN ectodomain 
could not be assessed. To investigate further the role of the 
M2  hydrophobic  domain  on  membrane  orientation,  we 
wished to replace only the M2 signal/anchor domain with 
that of the HN signal/anchor domain. This was not possible 
for technical reasons, and therefore we used the signal/anchor 
region from another class II integral membrane protein, the 
paramyxovirus SV5 SH polypeptide (11). A cDNA molecule 
(MgSM) was constructed by site-specific mutagenesis of M2g, 
such that its 19-amino acid signal/anchor was replaced pre- 
cisely with the 23-residue uncleaved signal/anchor domain 
of the SH polypeptide. Plasmids were constructed so that the 
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ing and secretion of chimeric M2 
HN proteins. CV-I cells infected 
with recombinam SV-40 express- 
ing MMH  (A), MgMH  (B), or 
MgHH  (C)  were  pulse-labeled 
for  30  min  with  Tran-35S-label 
(lane P), and incubated in DME 
containing excess nonradioactive 
methionine. At each timepoint (in 
hours), the medium was removed, 
clarified by centrifugation (10,000 
g for 2 min), adjusted to 1% SDS 
and boiled.  Cells were lysed in 
1%  SDS  and  boiled.  Aliquots 
representing equal portions of  the 
cells and medium were diluted, 
immunoprecipitated  with  HN- 
specific antisera, and analyzed by 
SDS-PAGE on  10%  polyacryl- 
amide gels. Lane M,  marker of 
pulse-labeled  proteins;  lane  C, 
control sample of cell lysate im- 
munoprecipitated with preimmune 
sera; lane L SV5-infected  cell ly- 
sate  with  molecular  masses (in 
kilodaltons) indicated. Note in C 
that the fastest migrating species 
is also found in lysates incubated 
with preimmune sera. 
M2g and MgSM DNA molecules were adjacent to the bac- 
teriophage  "1"7 RNA  polymerase  promoter  (pGM2g  and 
pGMgSM).  To  investigate  the  membrane  orientation  of 
MgSM, CVI cells were infected with a recombinant vaccinia 
virus that expresses the T7 RNA polymerase (7) and then 
transfected with either pGM2g or pGMgSM. The cells were 
labeled  with  [35S]cysteine and  the M2-specific  polypeptides 
immunoprecipitated using the M2 monoclonal antibody. As 
shown in Fig.  7 A, the MgSM polypeptide has an electro- 
phoretic mobility similar to M2g (,,,20,000 Mr).  Treatment 
of M2g and MgSM with Endo H yielded polypeptide species 
with •15,000  Mr, consistent with the loss of one high man- 
nose N-linked carbohydrate chain (lanes 3 and 5). Glycosyla- 
tion of MgSM indicates  that its NH2 terminus has been trans- 
located across the ER membrane. The slightly slower elec- 
trophoretic migration of Endo H-treated M2g compared to 
wild-type M2 is in part due to the single N-acetylglucosamine 
residue  which  remains after Endo  H  treatment and  to the 
amino acid change in M2g. The protein of slower electro- 
phoretic mobility (,,o35,000  Mr) observed in lane 4  which 
changes mobility with Endo H  treatment (lane 5)  is of un- 
known origin, and may represent nonspecific precipitation of 
a vaccinia virus protein. 
To investigate if MgSM had been translocated completely 
across the membrane and was a soluble protein, or whether 
the hydrophobic domain stably anchored MgSM  in mem- 
branes,  the resistance of MgSM and M2g (as a control) to 
extraction by alkali was examined. As shown in Fig. 7 B, both 
M2g and MgSM were found in the pellet fractions and none 
could be detected in the supernatant fraction. These data in- 
dicate that the observed M~g and MgSM polypeptides are 
glycosylated and are stably integrated in membranes in the 
same orientation,  i.e.,  glycosylated lumenal  NH2 termini. 
Thus,  in  MgSM  the M~  NH2 terminus is correctly orien- 
tated,  even though  the SH hydrophobic signal/anchor has 
been inverted with respect to its  normal orientation in the 
membrane. 
Discussion 
The M2 protein of influenza virus is one of a small number 
of characterized integral membrane proteins with uncleaved 
signal/anchors that span the lipid bilayer once and are orien- 
tated with extracellular NH2 termini (17, 20, 30,  38). To at- 
tempt to understand the role of the protein domains which 
are  responsible for M2 assuming  an uncommon topology, 
we  have  constructed  hybrid  molecules  consisting  of ex- 
changes  of domains of the  M2 polypeptide with  domains 
from HN and SH, two class II integral membrane proteins 
encoded by the paramyxovirus SV5. The hybrid molecules 
MMH, MgMH, MgHH, and MgSM were examined for their 
membrane topology and a summary of the deduced orienta- 
tions is shown schematically in Fig.  8. 
The MMH and MgMH hybrid polypeptides, in which the 
M2  cytoplasmic tail  (55  residues)  was  replaced  with  the 
much larger ectodomain of HN (529 residues), was found in 
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and the M2/HN chimeric proteins. The ER membrane is depicted 
as two horizontal lines  separating the  lumenal and cytoplasmic 
compartments of the cell. Membrane proteins are drawn schemati- 
cally as vertical boxes with cross-hatched regions representing sig- 
nal/anchor domains.  -~  and Ndenote N-linked glycosylation sites 
and the NH2 terminus of the proteins, respectively. /, H, and II1 
are forms of the chimeric proteins as described in the text. 
Figure 7. Expression and analysis of Mzg and MgSM. (,4) Expres- 
sion and t/-Endo H treatment. CV-I cells were infected with recom- 
binant vaccinia virus vTF-3 which expresses the bacteriophage T7 
RNA polymerase (7) and were then transfected with pGMsg (lanes 
2 and 3) or pGMgSM (lanes 4 and 5), and labeled with [35S]cys- 
teine for 1 h. Cells were lysed in RIPA buffer, immunoprecipitated 
with Mz-specific monoclonal antibody, and appropriate samples 
digested with Endo H. Lanes 2 and 4, mock digested; lanes 3 and 
5, digested with Endo H. Lane I shows an immunoprecipitation of 
CV1 cells transfected with a nonspecific control plasmid (pGeml). 
Lane  W, marker  lane of wild-type M2 expressed from a recom- 
binant SV-40 (40). (B) Alkali extraction  of M2g and MgSM. Hybrid 
proteins were transiently expressed from pGM2g or pGMgSM and 
alkaline extraction was performed as described in Materials and 
Methods.  After centrifugation,  equal portions  of the  pellet  (P) 
and supernatant (S)  were immunoprecipitated with anti-M2 and 
analyzed by SDS-PAGE. 
two major forms (I and III). MMH and MgMH form I (Fig. 
8) is anchored in membranes and orientated with a lumenal 
NH2 terminus like M2. This conclusion is based on the ob- 
served  shift  in  electrophoretic  mobility  of  glycosylated 
MgMH as compared to MMH, the sensitivity of its cytoplas- 
mic  tail  to  protease digestion and  the  inability  to  extract 
MgMH  on alkali  treatment of microsomes.  On  the other 
hand, MMH (or MgMH) form III is a  soluble protein that 
is completely translocated across the ER membrane and ulti- 
mately secreted from cells. As both MMH form I and III can 
be  recognized by the  site-specific  Mz  NHs-terminal  anti- 
body, these two species do not differ by cleavage at the NHs 
terminus. In contrast, the soluble and secreted form IV from 
MMH  and  MgMH  was  not  recognized  by  the  antisera 
specific for the M2 NHs terminus and did not exhibit an al- 
tered electrophoretic mobility by addition of the Ms NH2- 
terminal glycosylation site.  These properties of form IV are 
consistent with it being a modified version of form III which 
lacks its NHz terminus, possibly due to the action of a sig- 
nal peptidase-like activity cleaving the hydrophobic domain, 
but  the  precise  cleavage  site  remains  to  be  determined. 
Cleavage of a membrane spanning domain has been reported 
previously for an altered form of the invariant chain of class 
II histocompatibility antigen (Iy), a class II integral mem- 
brane protein (18). 
The finding of soluble MMH and MgMH form III suggests 
that the membrane signal/anchor property of the Ms hydro- 
phobic domain sometimes can be overridden. Although the 
signal/anchor domain operated normally in form I, in form 
III it acted only as a signal sequence without anchoring abil- 
ity. Previous attempts to dissect membrane signaling proper- 
ties  from  membrane  anchoring  functions  by  deletion  of 
residues in the hydrophobic domain of Ms (12) and of class 
II integral membrane proteins (5,  19, 34) have been unsuc- 
cessful. In the case of MMH (and MgMH), the ability of the 
Mz hydrophobic domain to act as an anchor when the mole- 
cule is being synthesized and cotranslationally inserted into 
the membrane may be borderline due to the driving force of 
polypeptide chain elongation. It has been suggested that for 
a region to function as a membrane anchor it must be above 
a certain critical threshold of  hydrophobicity (6). In addition, 
the position of the hydrophobic domain within the protein is 
thought to play an important part in determining the value 
of the threshold of hydrophobicity: the threshold value is 
greater if the membrane spanning domain is in an internal 
position rather than an end position (6, 22). Thus, the altera- 
tion in the position of the hydrophobic domain due to the 
length of the cytoplasmic tail in MMH may also be a factor 
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the  M2  signal/anchor domain.  Although the  MMH  con- 
struction alone does not show which domain of M2 is im- 
portant for its topology in membranes,  the orientation of 
MMH (or MgMH) form I does suggest that the M2 COOH- 
terminal domain is not required for directing proper orien- 
tation. 
It has usually been considered that integral membrane pro- 
teins assume only one orientation. However, with the hybrid 
molecule MgHH  in  which the  M2  NH2-terminal  ectodo- 
main was substituted in place of the HN NH2-terminal  cyto- 
plasmic domain, the polypeptide chain was inserted into the 
membrane in two opposing orientations: form I  in the M2 
orientation and form II in the HN orientation (Fig. 8). The 
reversal of the usual topology of HN occurred about half the 
time as measured by accumulation, but this is difficult to 
quantitate because of the degradation of form I. Although the 
M2 NH2 terminus is strongly implicated in specifying the 
orientation of MgHH form I, other factors must be involved 
to explain the ability of the MgHH polypeptide to also adopt 
the opposite orientation which was found for form II. As 
MgMH  (NH2 terminus  translocated  in  all  species)  and 
MgHH (NH2 terminus translocated 50%  of species) differ 
only by the origin of their transmembrane domain, it is pos- 
sible that the nature of this domain influences membrane 
orientation in conjunction with the M2 NH2 terminus. 
To directly test the role of the M2 signal/anchor on mem- 
brane  topology,  we  constructed  a  molecule  (MgSM)  in 
which  the  M2  hydrophobic domain alone was  exchanged 
with that of the signal/anchor domain from SH, a class II in- 
tegral membrane protein (11). MgSM was found to have simi- 
lar properties to M2g,  in that both proteins are stably in- 
tegrated into membranes in the Ms orientation. These data 
indicate that the SH hydrophobic domain can still act as a sig- 
nal/anchor domain when inverted in membranes with respect 
to its original topology. In addition, they suggest that the 
membrane spanning domain of M2 alone is not responsible 
for directing the topology of M2, a  result consistent with 
previous work which indicated that for class II proteins, for- 
eign hydrophobic regions could function as a signal/anchor 
domain  (41). In  summary,  it  appears  that  the  M2  sig- 
nal/anchor domain initiates the initial insertion of the na- 
scent polypeptide into the ER membrane (12), and that in the 
large part signals outside of the M2 hydrophobic domain di- 
rect the membrane orientation. 
The initial interaction of the nascent polypeptide chain of 
both class I and II membrane proteins with the ER mem- 
brane may occur by a common mechanism (27, 32). It has 
been suggested that the signal sequence of a nascent polypep- 
tide is inserted as a loop structure into the ER membrane and 
that after membrane insertion, the NH2 terminus of the na- 
scent protein remains on the cytoplasmic side of the ER. It 
has also been suggested that the final orientation of a protein 
is determined by either the presence (in class I proteins) or 
absence (in class II proteins) of  both a signal peptidase cleav- 
age site and a COOH-terminal anchor domain (32).  How- 
ever, this latter idea does not adequately explain the mecha- 
nism by which the orientation of M2 is achieved. We have 
previously determined that the first step in the membrane in- 
tegration of M2 is mediated by the signal recognition parti- 
cle (12), suggesting that the initial interaction of this protein 
with the ER membrane is by the same mechanism as for class 
II integral membrane proteins, yet the latter have lumenal 
COOH termini.  If the signal/anchor domain of a  nascent 
M2 polypeptide is also inserted into the ER membrane as a 
loop, the flanking regions must contain signals different from 
those found in class II membrane proteins to direct the M2 
NH2-terminal domain across the ER membrane and retain 
the COOH-terminal region in the cytoplasm. It is possible 
that the distribution of charged residues flanking uncleaved 
signal/anchor regions is a major determining factor in pro- 
tein topology (8,  11,  12). 
Recently, it has been proposed that negatively charged do- 
mains may be more favorable for translocation across the ER 
membrane than positively charged regions (8).  For M2, the 
net charge of the 24-residue NH2-terminal  domain is  -3 
and is +2 for the first 24 residues of the COOH-terminal do- 
main (17). Thus, after presentation to the ER membrane as 
a loop structure, translocation of the negatively charged M2 
NH2-terminal domain may be  favored over the positively 
charged COOH:terminal flanking region. By contrast, the 
charge  distribution  surrounding  the  HN  signal/anchor is 
somewhat  different:  a  net  +1  for  the  17-residue  NH2- 
terminal tail and 0 for the first 17 residues in the COOH- 
terminal domain (9), and the positive charged NH2 termi- 
nus is cytoplasmic. Any mechanism for directing membrane 
topology based on charge distribution alone however, would 
probably have difficulty  accommodating the two observed op- 
posite orientations of the MgHH polypeptide. Elucidation of 
the role of the charged residues in determining the orienta- 
tion of M2 will require extensive further site-specific altera- 
tions in M2. 
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